Fair Game: EpiPen Price Rises Could Mean More Riches for Mylan Executives

Sunday, September 4, 2016 - 00:41 in Mathematics & Economics

Filings show that under a one-time stock grant created in 2014, top executives stand to reap riches at least partly on the back of price increases on the EpiPen.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net